LYPD8 levels are significantly decreased in colitis patients, and supplementation of LYPD8 proteins might maintain colonic homeostasis in colitis patients by inhibiting the motility of pathogenic bacteria, such as γ-proteobacteria [59,60]. The gene discussed is LYPD8; the disease is colitis.